학술논문

The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women
Document Type
article
Source
Journal of Hypertension. 32(10)
Subject
Reproductive Medicine
Biomedical and Clinical Sciences
Cardiovascular
Clinical Research
Estrogen
Clinical Trials and Supportive Activities
Aging
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Aged
Blood Pressure
Blood Pressure Determination
Estrogen Replacement Therapy
Estrogens
Conjugated (USP)
Female
Humans
Medroxyprogesterone Acetate
Middle Aged
Postmenopause
Women's Health
blood pressure
hormone therapy
hypertension
postmenopause
women
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Medical Physiology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Clinical sciences
Language
Abstract
ObjectivesMean and visit-to-visit variability (VVV) of blood pressure (BP) are associated with an increased cardiovascular disease risk. We examined the effect of hormone therapy on mean and VVV of BP in postmenopausal women from the Women's Health Initiative (WHI) randomized controlled trials.MethodsBP was measured at baseline and annually in the two WHI hormone therapy trials, in which 10 739 and 16 608 postmenopausal women were randomized to conjugated equine estrogens (CEEs, 0.625 mg/day) or placebo, and CEEs and medroxyprogesterone acetate (MPA, 2.5 mg/day) or placebo, respectively.ResultsAt the first annual visit (year 1), mean SBP was 1.04 mmHg [95% confidence interval (CI) 0.58, 1.50] and 1.35 mmHg (95% CI 0.99, 1.72) higher in the CEEs and CEEs and MPA arms, respectively, compared with the corresponding placebos. These effects remained stable after year 1. CEEs also increased the VVV of SBP (ratio of VVV in CEEs vs. placebo, 1.03; P